Your browser doesn't support javascript.
loading
Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset.
Ferguson, Jessica D; Tayyar, Ralph; Contreras, Gustavo; Kiener, Melanie; Zimmet, Alex N; Contag, Caitlin A; Rodriguez Nava, Guillermo; Tompkins, Lucy S; Shepard, John; Rosenthal, Ayelet; Subramanian, Aruna K; Pinsky, Benjamin A; Salinas, Jorge L.
  • Ferguson JD; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Tayyar R; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Contreras G; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Kiener M; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Zimmet AN; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Contag CA; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Rodriguez Nava G; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Tompkins LS; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Shepard J; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Rosenthal A; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Subramanian AK; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Pinsky BA; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
  • Salinas JL; Stanford University School of Medicine and Stanford Hospital & Clinics, Stanford, California.
Infect Control Hosp Epidemiol ; 44(12): 2078-2080, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37381726
ABSTRACT
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse-transcription polymerase chain reaction (rRT-PCR) strand-specific assay can be used to identify active SARS-CoV-2 viral replication. We describe the characteristics of 337 hospitalized patients with at least 1 minus-strand SARS-CoV-2 assay performed >20 days after illness onset. This test is a novel tool to identify high-risk hospitalized patients with prolonged SARS-CoV-2 replication.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article